Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc

Apoptosis

Volumn 11, Issue 8, 2006, Pages 1311-1319

  Bellmann, Kerstin ^a   Martel, Julie ^a   Poirier, Dominic J P ^a   Labrie, Mireille M ^a   Landry, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Akt PKB; c Myc; p38; Phosphoinositide 3 kinase (PI3K)

Indexed keywords

CISPLATIN; DOXORUBICIN; HYDROGEN PEROXIDE; INSULIN; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; PROTEIN P85; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; DEREGULATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CHROMONES; CISPLATIN; DOWN-REGULATION; DOXORUBICIN; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; INSULIN; MORPHOLINES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TAMOXIFEN; TRANSFECTION;

EID: 33745860464     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-8205-1     Document Type: Article

References (45)

1. Pelengaris S, Rudolph B, Littlewood T (2000) Action of Myc in vivo - proliferation and apoptosis. Curr Opin Genet Dev 10:100-105
2. Pelengaris S, Khan M, Evan GI (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109:321-334
3. Graeber TG, Osmanian C, Jacks T et al (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91
4. Evan GI, Wyllie AH, Gilbert CS et al (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
5. Benhar M, Dalyot I, Engelberg D, Levitzki A (2001) Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21:6913-6926
6. Chen G, Shu J, Stacey DW (1997) Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene 15:1643-1651
7. Duelli DM, Lazebnik YA (2000) Primary cells suppress oncogene-dependent apoptosis. Nat Cell Biol 2:859-862
8. Rao L, Debbas M, Sabbatini P et al (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89:7742-7746
9. Basu A, Cline JS (1995) Oncogenic transformation alters cisplatin-induced apoptosis in rat embryo fibroblasts. Int J Cancer 63:597-603
10. Brown JM, Wouters BG (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59:1391-1399
11. Letai A, Bassik MC, Walensky LD et al (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2:183-192
12. Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346(Pt 3):561-576
13. Downward J (2004) PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15:177-182
14. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628
15. Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851-858
16. Mitchell KO, Ricci MS, Miyashita T et al (2000) Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res 60:6318-6325
17. Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19:8469-8478
18. Deng X, Xiao L, Lang W et al (2001) Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem 276:23681-23688
19. Torcia M, De Chiara G, Nencioni L et al (2001) Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J Biol Chem 276:39027-39036
20. Deschesnes RG, Huot J, Valerie K, Landry J (2001) Involvement of p38 in Apoptosis-associated Membrane Blebbing and Nuclear Condensation. Mol Biol Cell 12:1569-1582
21. Desbiens KM, Deschesnes RG, Labrie MM et al (2003) c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Biochem J 372:631-641
22. Yu K, Ravera CP, Chen YN, McMahon G (1997) Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2. Cell Growth Differ 8:731-742
23. Juin P, Hueber AO, Littlewood T, Evan G (1999) c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 13:1367-1381
24. Soucie EL, Annis MG, Sedivy J et al (2001) Myc potentiates apoptosis by stimulating bax activity at the mitochondria. Mol Cell Biol 21:4725-4736
25. Juin P, Hunt A, Littlewood T et al (2002) c-Myc functionally cooperates with Bax to induce apoptosis. Mol Cell Biol 22:6158-6169
26. Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL (2001) Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol 21:7653-7662
27. Harrington EA, Bennett MR, Fanidi A, Evan GI (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. Embo J 13:3286-3295
28. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E et al (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544-548
29. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN (1997) Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 94:3627-3632
30. Arboleda MJ, Lyons JF, Kabbinavar FF et al (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63:196-206
31. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23:1686-1690
32. Tremblay F,Lavigne C, Jacques H, Marette A (2003) Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes 52:29-37
33. Scheid MP, Woodgett JR (2003) Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett 546:108-112
34. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30:194-204
35. Kim AH, Khursigara G, Sun X, Franke TF, Chao MV (2001) Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1. Mol Cell Biol 21:893-901
36. Yuan ZQ, Feldman RI, Sussman GE et al (2003) AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 278:23432-23440
37. Liao Y, Hung MC (2003) Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis. Mol Cell Biol 23:6836-6848
38. Cuevas BD, Lu Y, Mao M et al (2001) Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J Biol Chem 276:27455-27461
39. Neiman PE, Ruddell A, Jasoni C et al (2001) Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci US A 98:6378-6383.
40. Fernandez PC, Frank SR, Wang L et al (2003)Genomic targets of the human c-Myc protein. Genes Dev 17:1115-1129
41. Liao Y, Hung MC (2004) A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells. Cancer Res 64:5938-5942
42. Goberdhan DC, Wilson C (2003) PTEN: tumour suppressor, multifunctional growth regulator and more. Hum Mol Genet 12:R239-R248
43. Harrison M, Li J, Degenhardt Y, Hoey T, Powers S (2004) Wip1-deficient mice are resistant to common cancer genes. Trends Mol Med 10:359-361
44. Bulavin DV, Saito S, Hollander MC et al (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. Embo J 18:6845-6854
45. Viniegra JG, Losa JH, Sanchez-Arevalo VJ et al (2002) Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin. Oncogene 21:7131-7136